Xiaoguang Dou Selected Research

Xiaoguang Dou Research Topics

Disease

18	Chronic Hepatitis B 01/2023 - 05/2013
13	Fibrosis (Cirrhosis) 10/2023 - 01/2012
10	Infections 10/2022 - 09/2002
10	Hepatitis B 10/2022 - 01/2013
7	Liver Diseases (Liver Disease) 09/2023 - 03/2014
6	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 10/2018
4	Hepatitis 10/2022 - 03/2015
4	Inflammation (Inflammations) 10/2022 - 08/2012
3	Chronic Hepatitis C 08/2015 - 03/2015
2	Ascites 01/2016 - 01/2012
2	Peritonitis 01/2016 - 01/2012
2	Coinfection 04/2014 - 03/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Hyperammonemia 12/2022
1	Vomiting 12/2022
1	Coma (Comas) 12/2022
1	Abdominal Obesity 01/2021
1	Obesity 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Disease Progression 01/2020
1	Hepatitis E 01/2020
1	Varicose Veins (Varicose Vein) 01/2020
1	Liver Failure 01/2019
1	Neoplasms (Cancer) 12/2018
1	Vitamin D Deficiency 02/2018
1	Viremia 01/2018
1	Hepatitis C 09/2015
1	Goiter 03/2015
1	Nodular Goiter 03/2015
1	Intravenous Substance Abuse 03/2014
1	Carcinogenesis 08/2012
1	Chronic Pancreatitis 08/2012

Drug/Important Bio-Agent (IBA)

13	Hepatitis B e AntigensIBA 01/2023 - 01/2013
9	Antiviral Agents (Antivirals)IBA 09/2023 - 03/2014
8	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 09/2002
7	Alanine Transaminase (SGPT)IBA 10/2022 - 03/2014
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2020 - 01/2013
5	InterferonsIBA 09/2019 - 08/2015
4	AntigensIBA 01/2020 - 08/2016
4	Vitamin D FDA LinkGeneric 02/2018 - 01/2012
3	NucleotidesIBA 01/2020 - 09/2002
3	hydroxide ionIBA 02/2018 - 01/2012
2	Indicators and Reagents (Reagents)IBA 10/2022 - 08/2012
2	NucleosidesIBA 01/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2014
2	lipoarabinomannan (LAM)IBA 01/2020 - 08/2016
2	Aldo-Keto Reductase Family 1 member B10IBA 12/2018 - 10/2018
2	EnzymesIBA 05/2018 - 06/2002
2	Telbivudine FDA Link 01/2018 - 04/2014
2	Lamivudine (Epivir)FDA Link 08/2016 - 04/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2014 - 03/2014
1	Cell-Free Nucleic AcidsIBA 10/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023
1	Nucleosomes (Nucleosome)IBA 10/2023
1	Plant ExtractsIBA 09/2023
1	nasIBA 01/2023
1	AmmoniaIBA 12/2022
1	phosphoserine aminotransferase (phosphoserine transaminase)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 03/2020
1	Contrast MediaIBA 01/2020
1	CelluloseIBA 01/2020
1	entecavir FDA Link 09/2019
1	Interleukin-2 (IL2)IBA 09/2019
1	VaccinesIBA 09/2019
1	Oxidoreductases (Dehydrogenase)IBA 10/2018
1	ImmunosorbentsIBA 05/2018
1	Biomarkers (Surrogate Marker)IBA 05/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2018
1	peginterferon alfa-2a (Pegasys)FDA Link 03/2018
1	Interferon-alpha (Interferon Alfa)IBA 03/2018
1	ORALIT (ORS)IBA 11/2016
1	Methionine (L-Methionine)FDA Link 08/2016
1	Aspartic Acid (Aspartate)FDA Link 08/2016
1	Tyrosine (L-Tyrosine)FDA Link 08/2016
1	VitaminsIBA 01/2016
1	25-hydroxyvitamin DIBA 01/2016
1	D-LL-37IBA 01/2016
1	Ribavirin (Virazole)FDA LinkGeneric 08/2015
1	AutoantibodiesIBA 03/2015
1	Hepatitis C AntibodiesIBA 04/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2013
1	hepatitis B hyperimmune globulinIBA 01/2013
1	Alkaline PhosphataseIBA 01/2013
1	collagen type I trimeric cross-linked peptideIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	pyridinolineIBA 01/2013
1	OsteoprotegerinIBA 01/2013
1	Sulindac (Copal)FDA LinkGeneric 08/2012
1	CeruletideIBA 08/2012
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2012
1	Antimicrobial PeptidesIBA 01/2012

Therapy/Procedure

12	Therapeutics 09/2023 - 03/2014
1	Treatment Delay 12/2022
1	Oral Administration 01/2020
1	Liver Transplantation 01/2019
1	Tattooing 03/2014
1	Chemoprevention 08/2012